VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952. A total of 4 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $515,000 | -12.7% | 3,600 | -20.0% | 0.01% | -27.3% |
| Q3 2014 | $590,000 | -64.6% | 4,500 | -65.9% | 0.01% | -57.7% |
| Q2 2014 | $1,665,000 | -66.4% | 13,200 | -64.9% | 0.03% | -58.1% |
| Q1 2014 | $4,957,000 | +44.1% | 37,600 | +28.3% | 0.06% | +63.2% |
| Q4 2013 | $3,440,000 | +29.8% | 29,300 | +15.4% | 0.04% | +11.8% |
| Q3 2013 | $2,650,000 | – | 25,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valtura Capital Partners LLC | 1,511,600 | $39,755,000 | 1.68% |
| SIMPLEX TRADING, LLC | 11,589 | $17,876,000 | 1.42% |
| GLENHILL ADVISORS LLC | 26,953 | $16,279,000 | 0.99% |
| GROUP ONE TRADING, L.P. | 1,551,900 | $40,815,000 | 0.58% |
| Marathon Trading Investment Management LLC | 96,700 | $2,543,000 | 0.48% |
| Pentwater Capital Management LP | 2,419,800 | $63,641,000 | 0.47% |
| Hudson Bay Capital Management LP | 105,000 | $2,762,000 | 0.13% |
| CMT Asset Management Ltd | 67,900 | $1,786,000 | 0.12% |
| Citadel Advisors | 1,980,900 | $52,098,000 | 0.07% |
| SG Americas Securities, LLC | 500,000 | $2,500,000 | 0.02% |